Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis

被引:4
作者
Kyrcz-Krzemien, Slawomira [1 ]
Helbig, Grzegorz [1 ]
Torba, Karolina [1 ]
Koclega, Anna [1 ]
Krawczyk-Kulis, Malgorzata [1 ]
机构
[1] Silesian Med Univ, Sch Med Katowice, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland
关键词
Autologous hematopoietic stem cell transplantation; Multiple sclerosis; Mobilization; Safety; AUTOIMMUNE-DISEASES; MARROW-TRANSPLANTATION; FOLLOW-UP; BLOOD; TOXICITY; SCT;
D O I
10.1179/1607845415Y.0000000049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Multiple sclerosis (MS) is a T-cell-mediated chronic inflammatory disorder of the central nervous system. Several agents have been approved for the treatment of MS; however, their efficacy is limited and short term. Autologous hematopoietic stem cell (HSC) transplantation may remain an encouraging option for some MS patients who failed prior conventional treatment. Objective: To assess the safety and effectiveness of HSCs mobilization in patients with MS. Material and methods: Thirty-nine patients (20 females and 19 males) with relapsing-remitting MS at median age of 40 years (range: 25-63) were included in this study. As a stem cell mobilization, they received either granulocyte colony-stimulating factor (G-CSF) alone (10 mu g/kg s.c. daily; n = 1) or cyclophosphamide (CY; 2.0 g/m(2) i.v. on days 1-2) followed by G-CSF (n = 38). Results: The median number of mobilized HSCs per kg was 6.32 x 10(6) (range: 2.64-26.3 x 10(6)). One apheresis was sufficient for collection of HSCs in 30 out of 39 MS patients (77%). Two aphereses were required for seven patients, three for one and four for one (17, 3, and 3%; respectively). Side effects of HSCs mobilization have been reported for eight patients (30%) and they were following: Staphylococcus epidermidis bacteremia (n = 1), fever of unknown origin (n = 3), diarrhea (n = 3), and headache (n = 1). Conclusions: Mobilization using CY and/or G-CSF resulted in effective mobilization in all MS patients. This procedure was found to be safe. No fatal outcome has been reported.
引用
收藏
页码:42 / 45
页数:4
相关论文
共 50 条
[41]   Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned [J].
Atkins, Harold L. ;
Freedman, Mark S. .
NEUROTHERAPEUTICS, 2013, 10 (01) :68-76
[42]   Mobilization of hematopoietic stem cells: state of the art [J].
Levesque, Jean-Pierre ;
Winkler, Ingrid G. .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2008, 13 (01) :53-58
[43]   Mobilization of hematopoietic stem cells into the peripheral blood [J].
Damon, Lloyd E. ;
Damon, Lauren E. .
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (06) :717-733
[44]   Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature [J].
Patti, Francesco ;
Chisari, Clara Grazia ;
Toscano, Simona ;
Arena, Sebastiano ;
Finocchiaro, Chiara ;
Cimino, Vincenzo ;
Milone, Giuseppe .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
[45]   Stem cell transplantation for multiple sclerosis [J].
Stellmann, J-P. ;
Stuerner, K. H. ;
Ufer, F. ;
Havemeister, S. ;
Poetgen, J. ;
Ayuketang, F. Ayuk ;
Kroeger, N. ;
Friese, M. A. ;
Heesen, C. .
NERVENARZT, 2015, 86 (08) :989-996
[46]   Outcomes of patients after mobilization failure of hematopoietic stem cells for autologous stem cell transplantation [J].
Santinelli-Pestana, Diego Vinicius ;
Chaer, Livia Netto ;
Mariano, Livia ;
Otuyama, Leonardo Jun ;
Medrone Junior, Alfredo ;
Rocha, Vanderson .
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (03) :256-260
[47]   Hematopoietic stem cell transplantation in multiple sclerosis [J].
Karussis, Dimitrios ;
Petrou, Panayiota ;
Vourka-Karussis, Urania ;
Kassis, Ibrahim .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (05) :567-578
[48]   Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis [J].
Mohammadi, Reihane ;
Aryan, Alisam ;
Omrani, Mir Davood ;
Ghaderian, Sayyed Mohammad Hossein ;
Fazeli, Zahra .
BIOLOGICS-TARGETS & THERAPY, 2021, 15 :53-59
[49]   Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis [J].
Shevchenko, Jury L. ;
Kuznetsov, Alexey N. ;
Ionova, Tatyana I. ;
Melnichenko, Vladimir Y. ;
Fedorenko, Denis A. ;
Kartashov, Andrei V. ;
Kurbatova, Kira A. ;
Gorodokin, Gary I. ;
Novik, Andrei A. .
EXPERIMENTAL HEMATOLOGY, 2012, 40 (11) :892-898
[50]   Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis [J].
Etemadifar, Masoud ;
Afzali, Parisa ;
Abtahi, Seyed-Hossein ;
Ramagopalan, Sreeram V. ;
Nourian, Sayed-Mohammadamin ;
Murray, Richard T. ;
Fereidan-Esfahani, Mahboobeh .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2014, 18 (02) :119-125